Nuwellis expands Aquadex for pediatric fluid to two new hopstial systems

Nuwellis (NUWE) announced a meaningful step forward for children facing fluid overload with the recent expansion of its Aquadex SmartFlow therapy into two additional pediatric centers across the Southeastern United States. The company now has 47 pediatric centers that have adopted Aquadex therapy as part of their fluid management approach. “Pediatric patients require an added level of precision. The margin for error is narrow, and the clinical stakes are often immediate,” said John Jefferies, MD, MPH, FACC, FHFSA, Chief Medical Officer of Nuwellis. “That is why this expansion matters-it provides care teams with an additional therapeutic option for managing fluid overload in critically ill children.”